U. König

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives

H. Amthauer, A. Buck, M. Kreissl, 2021, Hormone and Metabolic Research.

Brain metastases in gastroesophageal cancers—an underestimated complication

V. Ellenrieder, A. König, D. Soll, 2021, Gastric Cancer.

Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology

H. Bohnenberger, K. Reuter-Jessen, P. Ströbel, 2023, Journal of personalized medicine.